Company Profile
Connect Biopharma Holdings Limited Stock Price, News & Analysis
- Ticker:
- CNTB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- China and listed in the U
Stock performance
2.19 USD (+0.46%)
Close
Last updated: August 6, 2026
135M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CNTB closed up 0.46% at $2.19. No new same-company headline was identified in the current news window.
Company overview
Business overview
Connect Biopharma is an immunology company focused on inflammatory and autoimmune diseases. Its story is built around developing targeted therapies for chronic immune-mediated conditions.
Geographic Base and Sector Classification
Connect Biopharma is headquartered in China and listed in the U.S. market. It sits in specialty immunology biotechnology.
Business Model Characteristics
The company depends on clinical data, translational confidence, and the ability to progress a focused inflammatory pipeline. Investors watch efficacy signals and strategic developments.
Position Within the Biotechnology Landscape
Connect occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs evidence that the platform can differentiate in a crowded area.
Future catalysts
Connect Biopharma’s catalysts are its inflammatory-disease programs, especially any update that clarifies whether the company can still build a credible immunology story. The market will care about human data.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Connect Biopharma Holdings Limited (CNTB)?
Connect Biopharma Holdings Limited (CNTB) most recently closed at 2.19 USD, a +0.46% move versus the previous session.
What is the market cap of Connect Biopharma Holdings Limited (CNTB)?
Connect Biopharma Holdings Limited currently has a market capitalization of 135M USD on BioPharmSignal.
What does Connect Biopharma Holdings Limited do?
Connect Biopharma is an immunology company focused on inflammatory and autoimmune diseases. Its story is built around developing targeted therapies for chronic immune-mediated conditions.
On which exchange is CNTB stock listed?
Connect Biopharma Holdings Limited (CNTB) is associated with NASDAQ, China and listed in the U, Biopharma.
What is Connect?
Connect Biopharma’s catalysts are its inflammatory-disease programs, especially any update that clarifies whether the company can still build a credible immunology story.
Which conditions is Connect Biopharma Holdings Limited targeting with Connect?
Connect Biopharma Holdings Limited is associated with immunology based on its company overview and current catalyst commentary.
How does Connect Biopharma Holdings Limited describe recent progress with Connect?
Connect Biopharma’s catalysts are its inflammatory-disease programs, especially any update that clarifies whether the company can still build a credible immunology story.
What is Biopharma?
Connect Biopharma is an immunology company focused on inflammatory and autoimmune diseases.